Jamie Dananberg

2019

In 2019, Jamie Dananberg earned a total compensation of $1.6M as Chief Medical Officer at Unity Biotechnology, a 67% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$182,005
Option Awards$780,473
Salary$428,500
Stock Awards$189,675
Other$11,200
Total$1,591,853

Dananberg received $780.5K in option awards, accounting for 49% of the total pay in 2019.

Dananberg also received $182K in non-equity incentive plan, $428.5K in salary, $189.7K in stock awards and $11.2K in other compensation.

Rankings

In 2019, Jamie Dananberg's compensation ranked 7,039th out of 13,971 executives tracked by ExecPay. In other words, Dananberg earned more than 49.6% of executives.

ClassificationRankingPercentile
All
7,039
out of 13,971
50th
Division
Manufacturing
2,699
out of 5,701
53rd
Major group
Chemicals And Allied Products
993
out of 2,200
55th
Industry group
Drugs
842
out of 1,886
55th
Industry
Pharmaceutical Preparations
620
out of 1,398
56th
Source: SEC filing on April 30, 2021.

Dananberg's colleagues

We found three more compensation records of executives who worked with Jamie Dananberg at Unity Biotechnology in 2019.

2019

Keith Leonard

Unity Biotechnology

Chief Executive Officer

2019

Robert Goeltz

Unity Biotechnology

Chief Financial Officer

2019

Nathaniel David

Unity Biotechnology

President

News

You may also like